IL17A and colitis: Pathogenic Th17 cells are well known for their role in promoting colitis as mice deficient for IL-17A do not show signs of inflammation following DSS treatment.61 Notably, IPA was able to suppress the IL-17A production by Th17 cells, which likely contributed to the protection against colonic inflammation.